Susquehanna International Group’s BioCardia BCDA Stock Holding History
Bought
Maintained
Sold
Other funds holding BCDA
CM
VCM
VFT
PP
XT
VF
Susquehanna International Group's BCDA Position: Q1 2026 in Review
Susquehanna International Group increased its BioCardia (BCDA) stake by 0.05% in Q1 2026, buying an estimated $23 and bringing the position to 38,827 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #12651.
Susquehanna International Group first reported a position in BCDA in Q3 2019 and has held it in 17 quarters since. The position peaked at $266K in Q3 2022. 18 funds tracked by Wall St. Rank hold BCDA as of Q1 2026.
- Susquehanna International Group held 38,827 shares of BioCardia worth $47K as of Q1 2026.
- Susquehanna International Group bought 18 BioCardia shares in Q1 2026, an estimated $23.
- BioCardia made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12651 holding.
- Susquehanna International Group first reported a position in BioCardia in Q3 2019 and has held it in 17 quarters since.
- Susquehanna International Group's BioCardia position peaked at $266K in Q3 2022.
- 18 funds tracked by Wall St. Rank held BioCardia as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.